Hyperbaric oxygen therapy has been used for years to prevent a side effect of head and neck cancer treatment called osteoradionecrosis. But does it work?
There’s more to stopping cancer from spreading than simply cutting out chocolate, despite what the headlines say.
We take a look at our latest immunotherapy clinical trial, testing a new drug for people with head and neck cancers.
Professor Richard Shaw, a mouth cancer specialist who helped create our new Oral Cancer Toolkit, explains why it differs from the NICE referral guidelines
Emma Shanks shares her story of being diagnosed with oral cancer, not once but four times in succession.
Our scientists are piecing together cancer’s family tree, uncovering clues that could help develop better treatments in the future.
In the second installment of our series on the HOPON clinical trial we hear from the research nurses who help to run the trial in Liverpool.